Literature DB >> 16059439

Group I mGluR-induced epileptogenesis: distinct and overlapping roles of mGluR1 and mGluR5 and implications for antiepileptic drug design.

Robert K S Wong1, Riccardo Bianchi, Shih-Chieh Chuang, Lisa R Merlin.   

Abstract

The group I metabotropic glutamate receptor subtypes, mGluR1 and mGluR5, have both distinct and overlapping actions in epileptogenesis. Data are reviewed revealing how activation of these receptor subtypes participates in the induction and maintenance of the long-lasting epileptiform discharges elicited in the hippocampal circuit. Differences in the cellular actions and regional distributions of mGluR1 and mGluR5 provide hints regarding the potential usefulness and limitations of subtype-specific antagonists as antiepileptic agents.

Entities:  

Year:  2005        PMID: 16059439      PMCID: PMC1176311          DOI: 10.1111/j.1535-7597.2005.05207.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN: 1535-7511            Impact factor:   7.500


  59 in total

1.  Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor.

Authors:  P Sillevis Smitt; A Kinoshita; B De Leeuw; W Moll; M Coesmans; D Jaarsma; S Henzen-Logmans; C Vecht; C De Zeeuw; N Sekiyama; S Nakanishi; R Shigemoto
Journal:  N Engl J Med       Date:  2000-01-06       Impact factor: 91.245

Review 2.  Physiological roles and therapeutic potential of metabotropic glutamate receptors.

Authors:  P Jeffrey Conn
Journal:  Ann N Y Acad Sci       Date:  2003-11       Impact factor: 5.691

Review 3.  Plasticity mechanisms underlying mGluR-induced epileptogenesis.

Authors:  Robert K S Wong; Shih-Chieh Chuang; Riccardo Bianchi
Journal:  Adv Exp Med Biol       Date:  2004       Impact factor: 2.622

4.  Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP.

Authors:  Y M Lu; Z Jia; C Janus; J T Henderson; R Gerlai; J M Wojtowicz; J C Roder
Journal:  J Neurosci       Date:  1997-07-01       Impact factor: 6.167

5.  Temporal lobe epilepsy associated up-regulation of metabotropic glutamate receptors: correlated changes in mGluR1 mRNA and protein expression in experimental animals and human patients.

Authors:  I Blümcke; A J Becker; C Klein; C Scheiwe; A A Lie; H Beck; A Waha; M G Friedl; R Kuhn; P Emson; C Elger; O D Wiestler
Journal:  J Neuropathol Exp Neurol       Date:  2000-01       Impact factor: 3.685

6.  Differential roles for mGluR1 and mGluR5 in the persistent prolongation of epileptiform bursts.

Authors:  Lisa R Merlin
Journal:  J Neurophysiol       Date:  2002-01       Impact factor: 2.714

7.  Differential plasma membrane distribution of metabotropic glutamate receptors mGluR1 alpha, mGluR2 and mGluR5, relative to neurotransmitter release sites.

Authors:  R Luján; J D Roberts; R Shigemoto; H Ohishi; P Somogyi
Journal:  J Chem Neuroanat       Date:  1997-10       Impact factor: 3.052

8.  Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy.

Authors:  B C Schroeder; C Kubisch; V Stein; T J Jentsch
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

9.  Determinants of metabotropic glutamate receptor-5-mediated Ca2+ and inositol 1,4,5-trisphosphate oscillation frequency. Receptor density versus agonist concentration.

Authors:  Mark S Nash; Michael J Schell; Peter J Atkinson; Neil R Johnston; Stefan R Nahorski; R A John Challiss
Journal:  J Biol Chem       Date:  2002-07-15       Impact factor: 5.157

10.  Role of synaptic metabotropic glutamate receptors in epileptiform discharges in hippocampal slices.

Authors:  Angela C Lee; Robert K S Wong; Shih-Chieh Chuang; Hee-Sup Shin; Riccardo Bianchi
Journal:  J Neurophysiol       Date:  2002-10       Impact factor: 2.714

View more
  20 in total

Review 1.  Targeting glutamate synapses in schizophrenia.

Authors:  Julie R Field; Adam G Walker; P Jeffrey Conn
Journal:  Trends Mol Med       Date:  2011-09-28       Impact factor: 11.951

2.  Development of Novel, CNS Penetrant Positive Allosteric Modulators for the Metabotropic Glutamate Receptor Subtype 1 (mGlu1), Based on an N-(3-Chloro-4-(1,3-dioxoisoindolin-2-yl)phenyl)-3-methylfuran-2-carboxamide Scaffold, That Potentiate Wild Type and Mutant mGlu1 Receptors Found in Schizophrenics.

Authors:  Pedro M Garcia-Barrantes; Hyekyung P Cho; Colleen M Niswender; Frank W Byers; Charles W Locuson; Anna L Blobaum; Zixiu Xiang; Jerri M Rook; P Jeffrey Conn; Craig W Lindsley
Journal:  J Med Chem       Date:  2015-10-08       Impact factor: 7.446

3.  Mechanisms of tau and Aβ-induced excitotoxicity.

Authors:  Susanne P Pallo; John DiMaio; Alexis Cook; Bradley Nilsson; Gail V W Johnson
Journal:  Brain Res       Date:  2015-12-28       Impact factor: 3.252

4.  Expression of mGlu Receptor Genes in the Hippocampus After Intoxication with Trimethyltin.

Authors:  E V Pershina; I B Mikheeva; E R Kamaltdinova; V I Arkhipov
Journal:  J Mol Neurosci       Date:  2018-11-30       Impact factor: 3.444

Review 5.  Driving cellular plasticity and survival through the signal transduction pathways of metabotropic glutamate receptors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Faqi Li
Journal:  Curr Neurovasc Res       Date:  2005-12       Impact factor: 1.990

6.  Unique signaling profiles of positive allosteric modulators of metabotropic glutamate receptor subtype 5 determine differences in in vivo activity.

Authors:  Jerri M Rook; Meredith J Noetzel; Wendy A Pouliot; Thomas M Bridges; Paige N Vinson; Hyekyung P Cho; Ya Zhou; Rocco D Gogliotti; Jason T Manka; Karen J Gregory; Shaun R Stauffer; F Edward Dudek; Zixiu Xiang; Colleen M Niswender; J Scott Daniels; Carrie K Jones; Craig W Lindsley; P Jeffrey Conn
Journal:  Biol Psychiatry       Date:  2012-11-07       Impact factor: 13.382

7.  Exploration of allosteric agonism structure-activity relationships within an acetylene series of metabotropic glutamate receptor 5 (mGlu5) positive allosteric modulators (PAMs): discovery of 5-((3-fluorophenyl)ethynyl)-N-(3-methyloxetan-3-yl)picolinamide (ML254).

Authors:  Mark Turlington; Meredith J Noetzel; Aspen Chun; Ya Zhou; Rocco D Gogliotti; Elizabeth D Nguyen; Karen J Gregory; Paige N Vinson; Jerri M Rook; Kiran K Gogi; Zixiu Xiang; Thomas M Bridges; J Scott Daniels; Carrie Jones; Colleen M Niswender; Jens Meiler; P Jeffrey Conn; Craig W Lindsley; Shaun R Stauffer
Journal:  J Med Chem       Date:  2013-10-09       Impact factor: 7.446

Review 8.  Therapeutic promise and principles: metabotropic glutamate receptors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Jinling Hou
Journal:  Oxid Med Cell Longev       Date:  2008 Oct-Dec       Impact factor: 6.543

Review 9.  Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders.

Authors:  P Jeffrey Conn; Craig W Lindsley; Jens Meiler; Colleen M Niswender
Journal:  Nat Rev Drug Discov       Date:  2014-09       Impact factor: 84.694

10.  mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning.

Authors:  Jennifer E Ayala; Yelin Chen; Jessica L Banko; Douglas J Sheffler; Richard Williams; Alexandra N Telk; Noreen L Watson; Zixiu Xiang; Yongqin Zhang; Paulianda J Jones; Craig W Lindsley; M Foster Olive; P Jeffrey Conn
Journal:  Neuropsychopharmacology       Date:  2009-03-18       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.